Psoriasis
News
Clobex Followed by Vectical Wallops Psoriasis
Major Finding: Eighty percent of patients were rated clear, almost clear, or mild at week 2, as were 93% at week 4, 92% at week 8, and 74% at week...
News
DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk
Major Finding: The relative risk of developing a first cancer with anti-TNF therapy vs.
News
Off-Label Uses for Biologics Growing
News
Ustekinumab 4-Year Data Show No Increased Cardiovascular Risk
Major Finding: The observed combined rate of MI, stroke, and cardiovascular death in psoriasis patients on ustekinumab for at least 4 years was 0....
News
Rare Lymphoma Reports Continue in Young Patients on TNF Blockers
News
Anti-TNFs in Pregnancy Study Advises Continued Caution
Major Finding: Among women who took anti–tumor necrosis factor drugs at the time of conception, 24% of pregnancies ended in spontaneous abortion...
News
Interrupting Biologics Possible, Not Ideal
News
TRACTISS to Study Rituximab Effects in Sjögren's Syndrome
Major Finding: TRACTISS is expected to start patient recruitment in July 2011 and will investigate the use of rituximab vs. placebo for the...